Form 4: West Pharmaceutical Services Director Lai Goldman Myla Acquires Shares

Director Lai Goldman Myla acquired 564 shares of West Pharmaceutical Services Inc. common stock on April 23, 2024.

Summary

• On April 23, 2024, Lai Goldman Myla, a director of West Pharmaceutical Services Inc., acquired 564 shares of common stock.
• The shares were acquired at a price of $0 per share.
• Following the transaction, Lai Goldman Myla beneficially owns 18,352.93 shares of West Pharmaceutical Services Inc. common stock.
• These shares are restricted stock units that will vest in full on the date of the next annual shareholder meeting and will be distributable under the terms of the Deferred Compensation Plan for Outside Directors.

Sentiment

Score: 5

Explanation: The document is a neutral regulatory filing reporting an insider transaction. It doesn't inherently convey positive or negative sentiment.

Positives

• The acquisition of shares by a director may signal confidence in the company's future prospects.

Future Outlook

The restricted stock units will vest in full on the date of the next annual shareholder meeting and will be distributable under the terms of the Deferred Compensation Plan for Outside Directors.

Industry Context

This filing is a routine disclosure of insider transactions, which are common in publicly traded companies. It provides transparency into the actions of company insiders.

Stakeholder Impact

• The transaction may have a minor positive impact on shareholder sentiment, as it indicates a director's investment in the company.

Next Steps

• The restricted stock units will vest on the date of the next annual shareholder meeting.

Key Dates